Z

Zyversa Therapeutics Inc
NASDAQ:ZVSA

Watchlist Manager
Zyversa Therapeutics Inc
NASDAQ:ZVSA
Watchlist
Price: 1.25 USD -0.79% Market Closed
Market Cap: 1.3m USD
Have any thoughts about
Zyversa Therapeutics Inc?
Write Note

Zyversa Therapeutics Inc
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zyversa Therapeutics Inc
Deferred Income Tax Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zyversa Therapeutics Inc
NASDAQ:ZVSA
Deferred Income Tax
$845k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Deferred Income Tax
$2.7B
CAGR 3-Years
-9%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Deferred Income Tax
$1.7B
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zyversa Therapeutics Inc's Deferred Income Tax?
Deferred Income Tax
845k USD

Based on the financial report for Dec 31, 2023, Zyversa Therapeutics Inc's Deferred Income Tax amounts to 845k USD.

What is Zyversa Therapeutics Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 1Y
-92%

Over the last year, the Deferred Income Tax growth was -92%.

Back to Top